Navigation Links
CloudLIMS Redefines Operations in COVID-19 Biobanks with its Ready-to-go-live COVID-19 LIMS

CloudLIMS, a leading provider of laboratory informatics, announces the launch of a ready-to-go-live COVID-19 LIMS. CloudLIMS is preconfigured with CDC approved COVID-19 biorepository SOPs and can be quickly set up in less than a week.

With the global pandemic gaining a strong foothold worldwide, CloudLIMS previously announced the offering of its flagship product, CloudLIMS Enterprise, free of charge to SARS-CoV-2 & COVID-19 research, testing laboratories, and biobanks to fight the COVID-19 pandemic. CloudLIMS now invites COVID-19 biobanks to use its product to manage COVID-19 specimens and associated metadata, streamline and automate workflows right from sample accessioning, quality control tests, the shipment of specimens to researchers, and for the safe disposal of expired specimens.

Quality biobanking of COVID-19 specimens is underpinned by standardization and best practices. CloudLIMS, an in the cloud COVID-19 LIMS, enables COVID-19 biobanks to follow international standards and guidelines including ISO 20387:2018, HIPAA, EU GDPR, ISBER Best Practices to maintain quality specimens. High-quality COVID-19 specimens accelerate clinical research and trials on COVID-19, on population-based cohort studies, viral genome mutation studies, and molecular epidemiological studies.

CloudLIMS' self-serve client portal enables researchers to place a procurement request for SARS-CoV-2 specimens and track request status in real-time. The client portal also enables researchers to place storage requests for COVID-19 specimens and attach notes for handling or storage of specimens.

CloudLIMS enables COVID-19 biobanks to mirror their storage and inventory, automatically assign storage locations to COVID-19 specimens, enabling them to quickly locate samples and safely handle them. It also helps manage control specimens obtained from healthy individuals 2-3 months before the outbreak. COVID-19 testing laboratories use control samples to determine the reliability of test results.

COVID-19 biobanks can seamlessly manage the training and competency of their staff in handling, processing, proper packaging, and shipment of COVID-19 specimens. CloudLIMS helps biobanks manage patient consent, anonymize Protected Health Information (PHI), and generate custom reports of COVID-19 specimens, patients, and studies in a few clicks.

CloudLIMS' Rest API is preconfigured to support integration with third-party software, such as patient registries, EMR, LIS, and instruments used in specimen quality control tests.

"As the number of COVID-19 positive cases continue to mount, accelerated clinical trials to develop a vaccine against COVID-19 are urgently needed. Biobanks serve as an indispensable tool to accelerate COVID-19 research and trials, enabling biobanks to provide needed samples for COVID-19 research. We have preconfigured CloudLIMS to support COVID-19 biobanking workflows," said Arun Apte, Chief Executive Officer at CloudLIMS. “CloudLIMS can be deployed within a week and can help biobanks manage an unprecedented influx of COVID-19 specimens while maintaining international standards for quality biobanking,” he further added.

About CloudLIMS

Established in 2013, CloudLIMS is an energetic team of professionals producing cutting edge laboratory software solutions, such as sample management software and LIMS. For more information, please visit:

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related medicine news :

1. CloudLIMS Achieves ISO 9001:2015 Certification
2. Further Extends the Capabilities of its Cloud-based LIMS, CloudLIMS Lite
3. CloudLIMS named in 20 Most Promising Pharma and Life Sciences Tech Solution Providers 2016 by CIOReview
4. CloudLIMS is awarded the Bronze for the Most Customer Friendly Company of the Year at the Fifth Annual Best in Biz Awards 2015
5. CloudLIMS is the Gold Winner at the 7th Annual 2015 Golden Bridge Awards Under the New Product and Services Category
6. CloudLIMS adds Dr. Carolyn Compton, Former Director at National Cancer Institute’s OBBR to its Scientific Advisory Board
7. Dr. Jim Vaught, ISBER President and Founding Member, Joins the Scientific Advisory Board of CloudLIMS
8. Marks its First Sale in the Food and Beverages Industry
9. New Dispensary in Los Angeles Redefines Cannabis Retail
10. Hillsides Employee Redefines the Meaning of Regifting to Bring Joy to Children in Foster Care
11. New Crutch Design Redefines Mobility
Post Your Comments:
(Date:8/11/2020)... ... August 11, 2020 , ... ... is offering a new line of sanitizers that are fragrance-free and gentle on ... have an unpleasant odor or potentially dangerous levels of toxic chemicals. This is ...
(Date:8/9/2020)... ... 2020 , ... Dr. Angela Abraham has been appointed as the first-ever Diversity ... be leading the drive to foster a more equitable and bias-free NECO community. , ... new initiative led by Black Eyecare Perspective and dedicated to increasing Black presence in ...
(Date:8/7/2020)... ROSEMONT, Ill. (PRWEB) , ... August 07, 2020 ... ... Medicaid Services (CMS) released the Physician Fee Schedule proposed rule for the 2021 ... care professional teams by devaluing the procedures they perform which help return patients ...
(Date:8/5/2020)... ... August 05, 2020 , ... AdventHealth Carrollwood has partnered with Bayshore Christian ... on Monday, August 12, 2020. AdventHealth provided the school with key strategies and implementation ... classroom setting. , “We are taking extra steps in our hospital and in ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... health industry, as president of the largest veterinarian-owned purchasing Cooperative in the United ... in various roles where she gained extensive knowledge and experience in the animal ...
Breaking Medicine News(10 mins):
(Date:8/5/2020)... ... August 04, 2020 , ... In an informal poll of ... majority voted for a refreshed Minnesota Twins “Minnie and Paul” logo that is more ... circa 1960. That was well before the civil rights movement in the United States. ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... COVID-19, An FDAnews Webinar, Wednesday, Aug. 19, 2020, 1:30 p.m.-3:00 p.m. EDT, ... never simple and COVID-19 has made it more challenging. From COVID-19 monitoring ...
(Date:8/3/2020)... ... , ... LaVoieHealthScience (LHS), an integrated investor and public relations consulting ... President, CEO and Founder of LHS, has been named to the PharmaVOICE 100 ... 100 has honored more than 1,500 industry executives for their contributions to the life ...
Breaking Medicine Technology: